UPDATED – 2022 Safety Protocols

CHI has instituted mandatory health and safety protocols for all in-person participants. We are excited to bring our community back together in 2022, with trust and safety as our top priorities. All in-person participants are required to:

Have a negative COVID-19 test result from an FDA-authorized over-the-counter antigen test within 24 hours prior to arriving at the event. You will be asked your results at registration.

Immunogenicity Bioassay Summit - September 27-30, 2022

Registration Still Open! Register Today

Don't Miss an Minute of the Immunogenicity & Bioassay Summit!

Registered attendee, speakers and exhibitors were provided access through an email from our virtual event platform pathable.com. If you haven't received your access email, contact us now.

Conference Programs

Immunogenicity Assessment & Clinical Relevance

Immunogenicity Prediction & Control

Optimizing Bioassays for Biologics

Symposium:
Immunology for Biotherapeutics

Workshop:
Biostatistics for Beginners

Short Courses

Join us at the #1 Immunogenicity & Bioassay Event in the U.S. Bringing Together Industry, Academia & Regulatory Authorities.
Hear 7 FDA Presentations!

CHI is excited to host its 14th Annual Immunogenicity & Bioassay Summit at the Crystal Gateway Marriott in Washington, D.C. We’ll examine challenges facing the industry with NEW case studies, NEW perspectives and NEW approaches. Learn from industry, academia and the FDA at 3 Conference Programs, Symposium, Training Seminar, Workshop and 4 Short Courses. Once again, we’ll host interactive breakouts on various niche topics so delegates can share experiences and generate new ideas. Plus, attend an exhibit and poster hall with innovative products & services.

Select an In-person or virtual option, and you have the flexibility to switch your preferred event experience at any time leading up to the conference.